Prolactin, DHEA, and Adjunct Hormonal Markers in Androgen Evaluation

Training Video In Production 

It Will Be Posted Soon

1) Testosterone-First Orientation: Why Adjunct Markers Matter

A testosterone-first orientation treats every fatigue and libido complaint as an androgen problem and treats every borderline total as a trigger for therapy. Adjunct markers matter because they often explain why symptoms and testosterone values do not line up, and why gonadotropin patterns look “wrong.” Prolactin can suppress reproductive signaling and alter libido and mood. Adrenal markers can reflect stress physiology and metabolic context that dominate symptoms. Thyroid context can shift SHBG and change what totals mean. When clinicians ignore these variables, they misclassify and then chase the wrong lever. In the Testosteronology® framework, adjunct markers are used to build coherence, not to expand panels endlessly.

Adjunct markers should be ordered with purpose, not as reassurance. Each marker should answer a question: does this explain central suppression, does this explain binding context, does this explain symptom pattern, or does this trigger escalation. ABCDS™ remains relevant because the dominant drivers behind many adjunct abnormalities are also drivers of blood pressure drift, glycemic drift, sleep instability, and symptom volatility. This section sets the posture that adjunct markers are decision tools when used selectively and with method awareness.

2) Prolactin Physiology, Feedback, And Symptom Pathways

Prolactin is a bridge marker because it connects reproductive signaling, pituitary physiology, medication effects, and symptom narratives. Elevated prolactin can suppress GnRH pulsatility and reduce LH and FSH output, creating central suppression patterns. It can also contribute to libido changes and mood changes, though symptoms are nonspecific and often confounded. Prolactin is also sensitive to stress, sleep disruption, and the act of blood drawing itself, which makes single values easy to overinterpret. Clinicians should treat prolactin as a context signal and interpret it through timing, magnitude, and persistence.

A practical prolactin interpretation starts with the question of coherence. Does the prolactin result explain a low or inappropriately normal LH in the face of low testosterone. Does it explain a sudden libido decline when testosterone is stable. Does it fit with medication history. This section emphasizes that prolactin is most useful when it helps classify whether the axis is being suppressed centrally and why. ABCDS™ is relevant because sleep instability and stress physiology that raise prolactin also drive blood pressure and symptom volatility. The goal is to use prolactin to clarify the story rather than to create alarm from a single data point.

3) Prolactin Assays, Macroprolactin, And Common False Elevations

Prolactin assays have their own failure modes, and clinicians should know them because false elevations can lead to unnecessary imaging and anxiety. Macroprolactin is one common explanation for elevated measured prolactin with limited clinical effect, depending on the laboratory method and reporting. Stress during the draw, nipple stimulation, recent sexual activity, poor sleep, and acute illness can also elevate prolactin transiently. Many psychotropics and dopamine-modulating agents can elevate prolactin as well. The clinician should not treat an isolated mild elevation as a diagnosis without repeat confirmation under comparable conditions.

Practical reasons prolactin appears elevated when the patient does not have true pathologic hyperprolactinemia:

• Acute stress and poor sleep around the draw
• Medication effects, especially certain psychotropics
• Macroprolactin contribution depending on assay and lab handling
• Recent physiologic triggers that temporarily raise prolactin
• Lab variability and timing inconsistency across repeat draws

This section teaches clinicians to repeat thoughtfully, request macroprolactin evaluation when appropriate, and document why repeat confirmation is being done. The goal is to avoid false alarms while still catching true red flags.

4) When Prolactin Is A Red Flag: Escalation Triggers And Workup Logic

Prolactin becomes a red flag when the magnitude and persistence suggest true pathologic hyperprolactinemia or when symptoms suggest pituitary mass effect. Clinicians should not overreact to mild elevations, but they also should not ignore persistent significant elevation. Red flag interpretation requires staging: confirm the value under controlled conditions, review medications, rule out common benign explanations, then escalate if persistence remains. Imaging should be driven by pattern and magnitude, not by anxiety. This approach reduces unnecessary referrals while protecting against missed pathology.

Escalation triggers that should change clinician posture:

• Persistent significant elevation across repeat testing under stable conditions
• Visual symptoms, severe headaches, or other symptoms suggesting mass effect
• Marked libido collapse with clear central suppression pattern not explained by confounders
• Prolactin elevation that does not fit medication and lifestyle context
• Progressive worsening pattern rather than stable mild elevation

This section also addresses documentation. Notes should record the hypothesis, the repeat plan, the confounder review, and the rationale for escalation when needed. That keeps care defensible and coherent for future clinicians.

5) DHEA And Adrenal Androgen Physiology Across Men And Women

DHEA and adrenal androgen physiology matter because adrenal signaling can shape symptoms that are often blamed on testosterone. DHEA is a precursor hormone produced by the adrenal glands and serves as a substrate for downstream androgen and estrogen metabolism in certain tissues. Adrenal output is influenced by stress physiology, sleep, inflammation, age, and illness burden. In some patients, low DHEA-S may reflect chronic illness burden, catabolic stress, or aging rather than a discrete adrenal disorder. In others, higher adrenal androgen signals may reflect PCOS physiology or metabolic context in women. Clinicians should interpret adrenal markers as context signals, not as standalone diagnoses.

A key lesson is avoiding over-attribution. A borderline DHEA-S is rarely the primary explanation for complex fatigue, mood, or libido narratives. However, adrenal markers can help explain why androgen symptoms persist despite stable testosterone or why conversion patterns appear different. The Testosteronology® framework treats these markers as part of coherence checking, and coherence checking prevents clinicians from chasing one number. ABCDS™ helps because adrenal stress contexts often track with blood pressure patterns, sleep disruption, and metabolic drift that dominate symptoms and safety planning.

6) DHEA-S Versus DHEA: Selection, Stability, And Interpretation

DHEA-S is generally more stable than DHEA because of its longer half-life and less moment-to-moment fluctuation. That stability makes DHEA-S a more useful trend marker for many clinical questions. DHEA can fluctuate more with acute stress, timing, and short-term variability, which makes single values less informative. Clinicians should choose the marker that matches the clinical question and avoid ordering both without a clear reason. Trend integrity matters here because lab switching and timing differences can create artificial narratives.

Practical selection guidance clinicians can apply:

• Use DHEA-S when you need a more stable view of adrenal androgen substrate context
• Use repeat testing rather than a single value when the result will influence classification
• Interpret results within age context and illness burden context rather than treating them as targets
• Avoid over-attributing symptoms to DHEA when sleep and metabolic drivers are clearly dominant

This section reinforces the Testosteronology® posture of purposeful ordering and cautious interpretation.

7) Cortisol Context: Stress Signaling That Mimics Androgen Problems

Cortisol and stress signaling can create symptom pictures that look androgen-related, including fatigue, low motivation, sleep disruption, and mood volatility. Stress physiology can suppress GnRH pulsatility and reduce gonadotropin output, creating central suppression patterns that resemble hypogonadism. Patients often test during stressful periods when they feel worst, which increases the chance that values reflect suppression context rather than baseline physiology. Clinicians should treat stress context as a driver variable, not as background. When stress and sleep are unstable, dosing changes often create more volatility without improving the dominant driver.

A practical approach is to map symptom timeline to stress timeline, sleep timeline, and medication timeline. ABCDS™ helps because stress physiology often correlates with blood pressure drift, sleep instability, and glycemic trajectory drift. When cortisol-driven physiology is dominant, staged driver correction and repeat testing under stable conditions are often safer than immediate hormone escalation. This section trains clinicians to recognize stress-axis dominance and avoid turning short-horizon stress into long-horizon endocrine labeling.

8) Thyroid Proxies And SHBG Context: When Adjunct Markers Reframe The Panel

Thyroid context can reframe testosterone interpretation through SHBG shifts and symptom overlap. Hyperthyroid physiology can raise SHBG and create normal total values with low free fractions and persistent symptoms. Hypothyroid physiology can produce fatigue, weight change, low mood, and constipation that are often mislabeled as androgen deficiency. Thyroid proxies and SHBG context help clinicians decide whether the androgen story is primary or secondary to thyroid drift. This is a common cause of discordant panels where testosterone values look “fine” but symptoms persist, or testosterone values look “low” but the dominant driver is not androgen signaling.

Practical coherence checks that prevent misclassification:

• If SHBG shifted, ask what changed in thyroid status, weight trajectory, medications, or illness burden
• If symptoms are classic thyroid symptoms, stabilize thyroid context before labeling androgen deficiency
• If free and total discordance appears, interpret it through SHBG and timing rather than through targets
• If metabolic and sleep domains are drifting, treat drivers before escalating androgen therapy

ABCDS™ supports this because thyroid and metabolic drift often show up in blood pressure, lipid trajectory, and sleep stability which change risk tolerance.

9) Prostate And Gonadal Context Markers: What They Can And Cannot Prove

Certain markers are used to provide context rather than to prove causality. PSA trends are part of prostate monitoring, but PSA does not diagnose androgen deficiency and it does not define response. Testicular exam findings, fertility history, and gonadotropin patterns can support classification, but single markers rarely prove a single diagnosis. This section reinforces that adjunct markers should be interpreted as part of a coherent story. Overinterpreting a single marker leads to unnecessary fear or unnecessary reassurance.

Clinicians should also recognize that monitoring markers interact with therapy decisions. Rising hematocrit trends, blood pressure drift, and sleep instability can narrow safe options regardless of symptom improvement. ABCDS™ helps keep that visible and prevents clinicians from focusing on prostate narratives while ignoring broader safety drift. The Testosteronology® framework treats monitoring as long-horizon accountable care, and this section places these markers inside that posture.

10) Medication, Supplement, And Lifestyle Confounders That Shift Adjunct Markers

Adjunct markers are vulnerable to confounders because many are sensitive to stress, sleep, illness, and medications. Prolactin can be elevated by psychotropics and stress. DHEA-S can be influenced by illness burden and age context. Cortisol context can be influenced by sleep disruption and stimulants. Supplements can interfere with assays, especially biotin, and can also change symptom narratives through stimulant effects. Lifestyle cycles like dieting and overtraining can shift multiple axes simultaneously and create false endocrine narratives if clinicians interpret single values without context. This section teaches clinicians to treat confounder review as interpretive guardrails.

A practical confounder review is not a long list, it is a targeted timeline. What changed, when it changed, and what symptom changed after it. That habit often explains borderline labs better than additional testing does. ABCDS™ supports this because confounders often show up as sleep instability, blood pressure drift, and metabolic drift that help identify the dominant driver. This section helps clinicians avoid ordering more tests to solve a confounder problem.

11) A Structured Workflow For Ordering, Interpretation, And Documentation

Adjunct markers should be ordered as tools that answer specific questions, not as reassurance panels. A structured workflow starts with the chief complaint translated into testable hypotheses, then checks whether timing and confounders are controlled. If LH and FSH patterns do not fit, prolactin and medication review may clarify the driver. If symptoms and SHBG context are discordant, thyroid context and metabolic context may clarify interpretation. If fatigue and mood dominate with unstable sleep, cortisol context and sleep evaluation may be more relevant than another androgen marker. Documentation should state why the marker was ordered and what decision it will influence.

A practical adjunct-marker workflow that stays focused:

• Define the question the adjunct marker is meant to answer before ordering
• Control timing and confounders when possible and repeat when conditions were unstable
• Treat mild abnormalities as prompts for staged reassessment rather than immediate escalation
• Escalate evaluation when persistence, magnitude, or red flags justify it
• Document the reasoning chain and the next checkpoint so continuity is preserved

ABCDS™ can be referenced to keep follow-up grounded in domains that predict harm and to prevent adjunct markers from becoming a new set of trophy numbers.

12) Course Summary

This course taught adjunct markers as decision tools that clarify whether an androgen complaint is truly testosterone-driven or primarily driven by broader endocrine context. Prolactin was framed as a bridge marker that can suppress gonadotropin signaling and shape libido narratives, while also being vulnerable to false elevation and confounders. Macroprolactin, assay limits, and repeat confirmation were emphasized to prevent unnecessary imaging and unnecessary anxiety. DHEA and DHEA-S were framed as adrenal context markers that require age, illness, and stress interpretation rather than target chasing. Cortisol and stress physiology were emphasized as common drivers of reversible suppression and fatigue narratives mislabeled as androgen deficiency. Thyroid proxies and SHBG context were used to explain discordant panels and symptom-lab mismatch patterns. Prostate and gonadal context markers were framed as supportive signals rather than proof markers. Medication, supplement, and lifestyle confounders were emphasized as frequent drivers of apparent endocrine abnormalities. A structured workflow for ordering and documentation was provided to keep panels coherent and defensible. ABCDS™ was used to keep follow-up anchored to safety-domain trends when adjunct interpretation could otherwise drift into number chasing.

Recommended Grand Rounds Case Reviews